NeurologyLive Friday 5 — December 25, 2020


Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 25, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Expert Perspectives: Recent Approvals for Acute Migraine

Expert physicians consider the recent treatment approvals for the management of acute migraine, and how the shift in expectations outcomes has impacted treatment selection.

2: Reflections on the Impact of COVID-19: A Short Expert Series

This specialty series is dedicated to assessing the impact COVID-19 has had on the quality of life of patients with neurological disorders and the clinicians who were forced to adapt during this unique era of medical history.

3: Sleep Deprivation Among Frontline Health Care Workers During COVID-19 Turns Critical

The pandemic's impact stretches across all aspects of life and has particularly concerning effects on the sleep of those working on the frontlines providing care of patients.

4: Insights: Treatment Options for Dravet Syndrome

M. Scott Perry, MD, discusses historically approved therapies for the first-, second-, and third-line treatment of Dravet syndrome.

5: A Team Approach to Asleep Deep Brain Stimulation

Jason M. Schwalb, MD; Ellen L. Air, MD, PhD; Neepa J. Patel, MD; and Julia A. Wall discuss Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care that has helped it become a leading treatment center for Parkinson disease and related movement disorders.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.